Intesive Fludarabine-High Dose Cytarabine-Idarubicin Combination as Induction Therapy With Risk-Adapted Consolidation May Improve Treatment Efficacy in Younger Acute Myeloid Leukemia (AML) Patients: Rationales, Evidences and Future Perspectives

BioScience Trends - Japan
doi 10.5582/bst.2016.01221
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy